Annual report pursuant to Section 13 and 15(d)

Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity

v3.20.4
Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity - USD ($)
$ in Thousands
Total
Initial Public Offering
Convertible Preferred Stock
Common Stock
Common Stock
Initial Public Offering
Additional Paid-in Capital
Additional Paid-in Capital
Initial Public Offering
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance at Dec. 31, 2018 $ (10,690)         $ 1,762     $ (12,452)
Beginning balance, Shares at Dec. 31, 2018     12,393,047            
Beginning balance at Dec. 31, 2018     $ 43,921            
Beginning balance, Shares at Dec. 31, 2018       3,848,320          
Issuance of convertible preferred stock, net of issuance costs     $ 48,707            
Issuance of convertible preferred stock, net of issuance cost, Shares     6,963,788            
Issuance of common stock   $ 71,020         $ 71,020    
Issuance of common stock, Shares         7,275,501        
Issuance of common stock in conjunction with exercise of stock options 6         6      
Issuance of common stock in conjunction with exercise of stock options, Shares       5,667          
Exchange of convertible preferred stock, including deemed dividend (5,326)   $ 5,326     (1,762)     (3,564)
Conversion of convertible preferred stock into common stock 97,954         97,954      
Conversion of convertible preferred stock into common stock, Shares     (19,356,835)            
Conversion of convertible preferred stock into common stock     $ (97,954)            
Conversion of convertible preferred stock into common stock, Shares       12,904,534          
Stock-based compensation 2,300         2,300      
Net loss (16,943)               (16,943)
Ending balance at Dec. 31, 2019 $ 138,321         171,280     (32,959)
Ending balance, Shares at Dec. 31, 2019     0            
Ending balance, Shares at Dec. 31, 2019 24,034,022     24,034,022          
Issuance of common stock in conjunction with exercise of stock options $ 139         139      
Issuance of common stock in conjunction with exercise of stock options, Shares       25,611          
Issuance of common stock under employee stock purchase plan 29         29      
Issuance of common stock under employee stock purchase plan, Shares       3,142          
Net unrealized gains on available-for-sale securities 6             $ 6  
Stock-based compensation 4,388         4,388      
Net loss (33,339)               (33,339)
Ending balance at Dec. 31, 2020 $ 109,544         $ 175,836   $ 6 $ (66,298)
Ending balance, Shares at Dec. 31, 2020     0            
Ending balance, Shares at Dec. 31, 2020 24,062,775     24,062,775